6CRG
Crystal Structure of Shp2 E76K GOF Mutant in complex with SHP099
Summary for 6CRG
Entry DOI | 10.2210/pdb6crg/pdb |
Related | 6CRF |
Descriptor | Tyrosine-protein phosphatase non-receptor type 11, 6-(4-azanyl-4-methyl-piperidin-1-yl)-3-[2,3-bis(chloranyl)phenyl]pyrazin-2-amine, SULFATE ION, ... (5 entities in total) |
Functional Keywords | shp2, ptpn11, protein tyrosine phosphatase, e76k, gain of function mutant, allosteric inhibitor, hydrolase-hydrolase inhibitor complex, phosphatase, hydrolase/hydrolase inhibitor |
Biological source | Homo sapiens (Human) |
Total number of polymer chains | 2 |
Total formula weight | 122175.27 |
Authors | |
Primary citation | LaRochelle, J.R.,Fodor, M.,Vemulapalli, V.,Mohseni, M.,Wang, P.,Stams, T.,LaMarche, M.J.,Chopra, R.,Acker, M.G.,Blacklow, S.C. Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition. Nat Commun, 9:4508-4508, 2018 Cited by PubMed: 30375388DOI: 10.1038/s41467-018-06823-9 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.75 Å) |
Structure validation
Download full validation report